Arndt Vogel Selected Research

Arndt Vogel Research Topics

Disease

83	Hepatocellular Carcinoma (Hepatoma) 02/2024 - 10/2009
69	Neoplasms (Cancer) 03/2024 - 08/2008
18	Fibrosis (Cirrhosis) 09/2023 - 09/2009
15	Cholangiocarcinoma 01/2023 - 10/2014
12	Disease Progression 05/2024 - 07/2014
12	Biliary Tract Neoplasms (Biliary Tract Cancer) 05/2024 - 08/2014
12	Liver Diseases (Liver Disease) 01/2023 - 02/2004
10	Colorectal Neoplasms (Colorectal Cancer) 02/2024 - 11/2014
9	Neoplasm Metastasis (Metastasis) 11/2019 - 07/2013
8	Inflammation (Inflammations) 03/2024 - 12/2012
8	Liver Neoplasms (Liver Cancer) 10/2023 - 10/2004
8	Pancreatic Neoplasms (Pancreatic Cancer) 05/2022 - 06/2003
7	Liver Cirrhosis (Hepatic Cirrhosis) 07/2022 - 09/2017
5	Fatigue 08/2023 - 01/2015
5	Hypertension (High Blood Pressure) 01/2023 - 01/2015
5	Adenocarcinoma 01/2022 - 06/2003
5	Autoimmune Hepatitis 01/2020 - 01/2002
4	Non-alcoholic Fatty Liver Disease 08/2023 - 01/2020
3	Melanoma (Melanoma, Malignant) 01/2024 - 01/2017
3	Thrombocytopenia (Thrombopenia) 07/2023 - 10/2021
3	Hepatitis B 01/2022 - 07/2014
3	Uveal melanoma 12/2021 - 06/2017
3	Cholestasis 12/2021 - 01/2006
3	Infections 02/2019 - 12/2012
2	Overweight 08/2023 - 01/2022
2	Hemorrhage 07/2023 - 01/2021
2	Portal Hypertension 01/2023 - 01/2021
2	Liver Failure 02/2022 - 04/2008
2	Hepatitis 01/2022 - 02/2006
2	Neutropenia 10/2021 - 01/2019
2	Sarcoma (Soft Tissue Sarcoma) 01/2021 - 11/2014
2	Carcinoma (Carcinomatosis) 11/2020 - 02/2020
2	Asthenia 08/2020 - 07/2014
2	Ascites 08/2020 - 01/2017
2	Fatty Liver 01/2020 - 11/2016
2	Tyrosinemias (Tyrosinemia) 10/2019 - 08/2008
2	Colonic Neoplasms (Colon Cancer) 01/2018 - 01/2017

Drug/Important Bio-Agent (IBA)

21	Sorafenib (BAY 43-9006)FDA Link 12/2023 - 06/2014
16	Biomarkers (Surrogate Marker)IBA 02/2024 - 10/2003
14	Immune Checkpoint InhibitorsIBA 05/2024 - 01/2018
14	Bevacizumab (Avastin)FDA Link 12/2023 - 01/2021
14	atezolizumabIBA 12/2023 - 10/2018
13	Gemcitabine FDA Link 05/2024 - 08/2014
11	Proteins (Proteins, Gene)FDA Link 03/2024 - 02/2006
9	pembrolizumabIBA 01/2024 - 01/2018
8	Cisplatin (Platino)FDA LinkGeneric 05/2024 - 05/2013
8	Melphalan (Alkeran)FDA LinkGeneric 07/2023 - 01/2017
8	lenvatinibIBA 06/2022 - 01/2018
6	Irinotecan (Camptosar)FDA LinkGeneric 11/2023 - 05/2005
6	BilirubinIBA 10/2023 - 01/2015
5	AlbuminsIBA 10/2023 - 01/2008
5	alpha-Fetoproteins (alpha-Fetoprotein)IBA 05/2022 - 01/2020
5	Everolimus FDA Link 11/2020 - 08/2009
4	durvalumabIBA 05/2024 - 10/2018
4	Tyrosine Kinase InhibitorsIBA 09/2023 - 01/2015
4	Aspartate Aminotransferases (Aspartate Transaminase)IBA 01/2023 - 09/2009
4	Alanine Transaminase (SGPT)IBA 01/2023 - 01/2018
4	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2022 - 06/2014
4	RamucirumabIBA 10/2021 - 01/2020
4	130-nm albumin-bound paclitaxelIBA 01/2021 - 11/2014
4	AntibodiesIBA 11/2018 - 11/2014
3	NivolumabIBA 01/2022 - 10/2018
3	Oxaliplatin (Eloxatin)FDA LinkGeneric 01/2022 - 11/2016
3	DNA (Deoxyribonucleic Acid)IBA 10/2020 - 06/2003
3	MicroRNAs (MicroRNA)IBA 03/2017 - 08/2013
3	Leukocyte L1 Antigen Complex (Calgranulin)IBA 12/2015 - 12/2012
3	AutoantibodiesIBA 02/2006 - 10/2003
2	Transcription Factors (Transcription Factor)IBA 03/2024 - 01/2020
2	CytokinesIBA 02/2024 - 12/2015
2	tislelizumabIBA 10/2023 - 06/2019
2	Messenger RNA (mRNA)IBA 07/2022 - 12/2021
2	Fluorouracil (Carac)FDA LinkGeneric 01/2022 - 01/2018
2	AcyltransferasesIBA 01/2022 - 10/2018
2	SirtuinsIBA 08/2021 - 01/2018
2	Mitogen-Activated Protein KinasesIBA 01/2021 - 01/2019
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2021 - 09/2009
2	Type II Tumor Necrosis Factor ReceptorsIBA 01/2021 - 01/2020
2	Type I Tumor Necrosis Factor ReceptorsIBA 01/2021 - 01/2020
2	PlatinumIBA 11/2020 - 08/2014
2	pemigatinibIBA 10/2020 - 01/2020
2	Fibroblast Growth Factor Receptors (Fibroblast Growth Factor Receptor)IBA 01/2020 - 01/2018
2	Phospholipases (Phospholipase)IBA 01/2020 - 10/2018
2	Monoclonal AntibodiesIBA 06/2019 - 11/2014
2	Antiviral Agents (Antivirals)IBA 02/2019 - 09/2017
2	AntigensIBA 02/2019 - 02/2006
2	VemurafenibIBA 01/2019 - 01/2018
2	Cholinesterases (Cholinesterase)IBA 01/2019 - 01/2017
2	Panitumumab (Vectibix)FDA Link 06/2018 - 01/2018
2	Cetuximab (Erbitux)FDA Link 06/2018 - 01/2018
2	Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA 01/2018 - 06/2014

Therapy/Procedure

74	Therapeutics 03/2024 - 02/2004
15	Immunotherapy 02/2024 - 01/2019
13	Drug Therapy (Chemotherapy) 11/2023 - 08/2014
12	Liver Transplantation 01/2023 - 02/2004
3	Hemofiltration 08/2021 - 10/2017
3	Transplantation 11/2019 - 02/2004
2	Neoadjuvant Therapy 12/2023 - 02/2020
2	Salvage Therapy 01/2023 - 12/2021
2	Radiotherapy 08/2021 - 01/2021
2	Adjuvant Chemotherapy 02/2020 - 07/2017